In patients with corpus uteri cancer, complex antitumor treatment containing thymalin showed pronounced modulation of T-cell-mediated immunity.
In plain wordsIn patients with uterine cancer, complex treatment containing thymalin changed T-cell immunity.
- Peptide
- Thymalin
- Outcome
- Direction not reportedT-cell-mediated immunity
- Study
n = 21
- Outcome group
- Immune response · Immune and inflammation
Source sentences
The results of a clinico-immunologic study of thymalin as a component of complex antitumor treatment of 21 cases of cancer of corpus uteri pointed to a pronounced immunomodulating action of the drug on T-cell-mediated immunity.
In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.